The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Lyxor S&P 500 UCITS ETF - Acc: Net Asset Value(s)

31 Jan 2020 17:08

Lyxor S&P 500 UCITS ETF - Acc (SP5C LN) Lyxor S&P 500 UCITS ETF - Acc: Net Asset Value(s) 31-Jan-2020 / 18:07 CET/CEST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Net Asset Value(s)

FUND: Lyxor S&P 500 UCITS ETF - Acc

DEALING DATE: 30-Jan-2020

NAV PER SHARE: EUR: 197.5511

NUMBER OF SHARES IN ISSUE: 8470367

CODE: SP5C LN

ISIN: LU1135865084


ISIN:LU1135865084
Category Code:NAV
TIDM:SP5C LN
Sequence No.:43981
EQS News ID:965601
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.